Mike Thompson, CEO of ABPI, commented that “the benefits of working together are important for all parties involved – better quality care, lower hospitalisations and more appropriate use of medicines”, before saying he hopes the guidelines “will give people in business and the NHS the confidence to cooperate in new ways and launch many new successful joint work projects”. ABPI publishes new guidelines on pharmaceutical work with patients The document contains legal guidelines on joint work to ensure that projects comply with data protection law and competition law and also specifies that joint work projects must be supported by a formal joint working agreement, the summary of which must be made public before the start of the project. The `toolbox` aims to ensure that working together between the NHS and industry generates `a triple win` for patients, NHS and businesses. The organisation explained that examples of joint work projects – defined as situations in which pharmaceutical companies, the NHS and other capacities, experiences and resources are pooled for the joint development of patient-centred projects – include identifying undiagnosed patients, improving patients` adhnity in medicines and contributions to care services. – facility efficiency measures, e.g. waiting times, contact points that can also be linked to patient experience indicators The partners involved, often healthcare professionals and industry representatives, define concepts that contribute to improved patient care and outcomes 1 www.pmcpa.org.uk/thecode/InteractiveCode2016/Pages/Clause20.aspx Defined outcomes are documented and a he case study of exchange of learning experiences is envisaged. – market expansion with a proportional increase in the appropriate use of specific Me Dicines, depending on local or national orientations – project schedules and miles – Description of grouped resources Further examples are available as executive summaries on the ABPI Disclosure UK2 website. You can also read case studies on joint work in Appendix 1 of this document and on the websites of ABPI members. Once the PID is approved, each party signs the Joint Working Agreement and a summary is published on the company`s website Joint Work Projects aim to achieve `triple benefits` in the form of benefits for patients, the NHS and the pharmaceutical operator(s) involved.
The expected benefits must be clearly stated in advance. Both the NHS organisation and the participating company may consider quantifying the expected benefits as an anticipated return on investment (ROI) before embarking on a joint work project. Each party involved reviews the project idea to ensure that it is consistent with its respective compliance objectives and processes – Changes in patient satisfaction/experience levels Representatives of each organization submit the PID for verification through its own internal governance structure a more detailed plan or a “Project Initiation Document” (PID) can be developed Each party must make a significant and defined contribution to the project. and. and transfers of value from enterprises must be made public. . . .